PALMERI, Sergio
PALMERI, Sergio
Medicina di Precisione in Area Medica, Chirurgica e Critica
"Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet"
2010-01-01 Comella, P;Casaretti, R;Manzo, R;Sandomenico, C; Licenziato, M;Avallone, A;Franco, L;Massidda, B;Filippelli, G;Putzu, C;Natale, D;Barberis, G;Maiorino, L; Palmeri, S;Cannone, M;Condemi, G;Leo, S;Tafuto, S;Greco, E;Roselli, M;Milia, V;Gambardella, A;Mancarella, S;Di Pinto, G;De Luca, L;Vessia, G
"Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with early (E) breast cancer (BC)”
2009-01-01 Palmeri, L; Vaglica, M; Mangiameli, A; Di Noto, L; Bongiovanni, A; Marchese, A; Palmeri, S
"Incidence of different KRAS mutation in non-small cell lung cancer (NSCLC) patients, TAILOR STUDY
2011-01-01 Martelli,O;Rulli,E;Bettini,A;Farina,G;Longo,F;Moscetti,L;Pavese,I;Alabiso,O;Bertolini,A;Tomirotti,M;Farris,A;Veronese,S;Ferrari,V;Marsoni,S;Lauricella,C;Ganzinelli,M;Broggini,M;Marabese,M;Floriani,I;Copreni,E;Bertolini,A;Pellegrino,A;Ardizzoia,A;Palmeri,S;Gherardi,G;Bianchi,F;Scanni,A;Garassino,MC
"Should cirrhosis change our attitude towards treating non-hepatic cancer?"
2012-01-01 Cabibbo, G; Palmeri, L; Palmeri, S; Craxì, A
"Unknown primary tumors"
2011-01-01 Natoli,C;Ramazzotti,V;Nappi,O;Giacomini,P; Palmeri,S;Salvatore,M;Landriscina,M;Zilli,M; Natali,PG;Tinari,N;Iacobelli,S
"Weekly docetaxel in the treatment of metastatic breast cancer"
2008-01-01 LAURA PALMERI; MARINA VAGLICA; PALMERI S
"Weekly regimen of cisplatin (CDDP),epirubicin (EPI), fluorouracil (5FU) and folinic acid (FA) with G-CSF is active in advanced gastroesophageal (GE) and gastric (G) cancer: results of a phase II study”
2005-01-01 PALMERI S; MC MACALUSO; MVAGLICA; GMODICA; LDI NOTO; GDI VITA; CSCIUM; GVETRI; EVASSALLO; GDI GES
Analisi della frequenza del polimorfismo 1249-1250insACAA del gene TGF-beta2 in un gruppo di pazienti affette da carcinoma della mammella.
2005-01-01 NUZZO D; SCOLA L; CANDORE G; DI NOTO L; BONGIOVANNI A; VAGLICA M; CRIVELLO A; FORTE GI; GIACALONE A; CARUSO C; LIO D; PALMERI S; Scola, L.
Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience
2011-01-01 Comella,P;Massidda,B;Natale,D;Putzu,C; Sandomenico,C;Filippelli,G;Palmeri,S;Condemi,G;Vessia,G;Barberis,G;Ionta,MT;Tafuto,S;Barbato, E
F3 the advantage of ultrasound-guided FNA of pleura in the diagnosis of the malignant pleural effusion
2005-01-01 CAJOZZO M; COCCHIARA G; BARTOLOTTA T; ROMEO M; RENDA A; ALTIERI G; VAGLICA R; PALMERI S; MODICA G
GASTRIC CANCER (GC) ADJUVANT (A) CHEMOTHERAPY (CT): A LITERATURE BASED META-ANALYSIS (MA)
2010-01-01 Palmeri, L; Matranga, D; Vaglica, M; Marchese, A; Frazzetta, M; Vetri, G; Di Noto, L; Bongiovanni, A; Liardo, E; Palmeri, S
Investigator-initiated trials of targeted oncology agents: why independent research is at risk?
2010-01-01 Bergmann, L; Berns, B; Dalgleish, AG; von Euler, M; Hecht, TT; Lappin, GL; Reed, N; Palmeri, S; Smyth, J; Embacher-Aichorn, S; Zwierzina, H
L’anemia nel paziente oncologico
2004-01-01 PALMERI S; SAVERSA; LSALVAGNO
Prognostic value of vascular endothelial growth factor (VEGF) and D-Dimer (DD) levels in cancer patients
2006-01-01 PALMERI S; A SAETTA; MC MACALUSO; M VAGLICA; CM PORRETTO; L PALMERI; L DI NOTO; A ACCARDO; C RAIMONDI; A BONGIOVANNI; P GIGLIONE; E VASSALLO
The effectiveness of the topical use of 0,2% glyceryl trinitrate to decrease post –hemorrhoidectomy pain and to improve wounds healing.
2004-01-01 MACCHIARELLA B; PATTI R; ARCARA M; PADRONAGGIO D; BONVENTRE S; ANGILERI M; SALERNO R; ROMANO P; BUSCEMI S; DI VITA G; Palmeri, S.
Weekly docetaxel (wDOC) for the treatment of metastatic breast cancer (MBC): A literature based meta-analysis
2010-01-01 Palmeri,L; Matranga,D; Vaglica,M; Di Noto,L; Bongiovanni,A; Marchese,A; Ancona,C; Frazzetta,M; Cajozzo,M; Palmeri,S
“A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer”
2005-01-01 DE PLACIDO S; DE LAURENTIIS M; DE LENA M; LORUSSO V; PARADISO A; DAPRILE M; PISTILLUCCI G; FARRIS A; SAROBBA MG; PALAZZO S; MANZIONE L; ADAMO V; PALMERI S; FERRAU F; LAURIA R; PAGLIARULO C; PETRELLA G; LIMITE G; COSTANZO R; BIANCO AR
“Analysis of interleukin 10 (IL-10)-1082 G/A single nucleotide polymorphism (SNP) genotypes in breast cancer (BC) patients (pts) and in >95 years old cancer free women"
2005-01-01 PALMERI S; DLIO; MVAGLICA; ACRIVELLO; E VASSALLO; GIFORTE MCMACALUSO; CRAIMONDI; AACCARDO; CCARUSO
“Analysis of serum HER-2/neu levels (S-HER2) in breast cancer (BC) patients (pts)”
2006-01-01 PALMERI S; AMANGIAMELI; MVAGLICA; RALLEGRO; MC MACALUSO; ABONGIOVANNI; L DI NOTO; DVASTA; LRACITI; DLIO
“Bevacizumab (Bev) with irinotecan (IRI), folinic acid (FA), and 5-fluorouracil (FU) i.v. every 2 weeks (BIFF regimen) as first-line treatment for metastatic colorectal cancer (MCRC) patients (pts): an observational study of the Southern Italy Cooperative Oncology Group (SICOG)”
2009-01-01 Comella, P; Massidda, B; Natale, D; Filippelli, G; Farris, A; Palmeri, S; Condemi, G; Tafuto, S; Vessia, G; Barberis, G; Sandomenico, C